Hope Remains For Alzheimer's Sufferers

... The National Institute of Clinical Excellence (NICE), who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (Aricept®), will hopefully re-appraise their decision in 3 years time, according to neurologist Professor Robert Kerwin in an article published in the November issue of the medical journal Future Neurology. [click link for full article] ...